Carl Zeiss Meditec (OTCMKTS:CZMWY) Lowered to Strong Sell Rating by Zacks Research

Zacks Research lowered shares of Carl Zeiss Meditec (OTCMKTS:CZMWY) from a hold rating to a strong sell rating in a report published on Monday morning,Zacks.com reports.

Separately, Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Carl Zeiss Meditec Stock Up 1.2%

Shares of OTCMKTS:CZMWY opened at $30.72 on Monday. Carl Zeiss Meditec has a 52 week low of $26.65 and a 52 week high of $72.57. The business has a fifty day simple moving average of $29.83 and a 200-day simple moving average of $37.46.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.